DJ

About Doc Juliette

Doc Juliette is a private limited company (BV/SRL) based in Mons, founded in 2025. For the 2025 financial year, Doc Juliette reported a profit of €15,610. Revenue was not published, which is common for abbreviated accounts. The gross margin came to €23,408. Equity stands at €20,610, a solvency ratio of 8.5%.

Juridical situation
Normal situation
Company number
1031.543.332
Founding date
Founded on 12-12-2025
EUID number
BEKBOBCE.1031.543.332
Type of enterprise
Rechtspersoon
Location
Clos Marie-Thérèse D'autriche 46 Mons 7011
Juridical form
BV — Private limited company (BV/SRL)
Activities
Signals
Poor liquidity
Profitable
Positive cashflow
Positive EBITDA

Financial ratios

Profit
€ 16K
Equity
€ 21K
Gross margin
€ 23K
Health
Solvability > 25%
8.5%
Liquidity > 1.0
0.17
Profitability > 0%
75.7%
2025
Gross margin
€ 23K
EBITDA
€ 23K
Profit
€ 16K
Equity
€ 21K
Solvability
8.54%
Debt
€ 221K
Cash
€ 30K

Frequently asked questions

Answers to the most common questions about Doc Juliette, based on official government data and the filed annual accounts.

What is the VAT number of Doc Juliette?

The VAT number of Doc Juliette is BE1031.543.332.

When was Doc Juliette established?

Doc Juliette was founded in 12-12-2025.

What is the official address of Doc Juliette?

The official address of Doc Juliette is Clos Marie-Thérèse D'autriche 46 Mons 7011.

What is the legal form of Doc Juliette?

The juridical form of Doc Juliette is Private limited company (BV/SRL).

What is the annual revenue of Doc Juliette?

The 2025 accounts of Doc Juliette do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.

Is Doc Juliette a reliable company?

Doc Juliette is a registered Rechtspersoon with company number 1031.543.332 and can be verified through the official CBE database.

What is the credit limit of Doc Juliette?

The estimated credit limit of Doc Juliette is €19,125.

Is Doc Juliette still active?

Doc Juliette currently has the status "Normal situation" and is active.

Further reading

View all insights

Sources